Recursion Tech Stack
Clinical-stage biotech platform automating drug discovery through biology datasets and AI
Recursion is a public clinical-stage biotech company (NASDAQ: RXRX) running a computational biology platform called the Recursion OS, which combines wet-lab automation (millions of experiments weekly), proprietary biological datasets, and machine-learning models to accelerate drug discovery. The hiring mix—research and data roles dominating the open requisitions, with sparse engineering and product—reflects a company bottlenecked on biology and analytics rather than software velocity; active projects span clinical pharmacology, structural biology, multi-omics representation learning, and generative models for drug discovery, while pain points cluster around data integration, making data discoverable, and industrializing analysis workflows.
Tech Stack 23 technologies
What Recursion Is Building
◆Challenges
- Data integration
- Expedite decision making
- Vendor oversight challenges
- Accelerating drug development funnel
- Industrializing analysis approaches
- Reducing reliance on traditional preclinical studies
- Making data discoverable
- Prioritizing project resourcing
- Accelerating drug discovery
- Operational and process improvements
▲Active Projects
- Clinical pharmacology and pharmacometric strategies for rare disease and oncology programs
- Clinical study design for phase 1-3 trials
- Next-generation structural biology methods
- Generative models for drug discovery
- Atomic/structural modeling
- Multi-omics representation learning
- Vendor oversight plan development
- Edc setup and database migration
- Identifying disease and patient linkages to -omics phenotypes
- Ind and clinical stage drug development programs
